CAMBRIDGE, Mass., March 24, 2015 /PRNewswire-USNewswire/ — Claritas Genomics will present data on the quality of parallel multi-technology sequencing, a comparison of the company’s phenotypically driven Pediatric Neurology Exome Assay to whole exome and panel-based approaches, three-part reports for rapid results reporting, and the clinical utility of the Neurology Exome’s tailored approach compared to other tests currently […]

Claritas Genomics Caps Landmark Year with New Investment After Launching Novel Diagnostic Tests for Childhood Disorders and Advancing the Application of Next-Gen Sequencing in Routine Clinical Care Begins 2015 with $15 Million Investment by NextCODE Health (now part of WuXi NextCODE Genomics), Boston Children’s Hospital, Cerner Corporation and Cincinnati Children’s Hospital Medical Center CAMBRIDGE, MASSACHUSETTS […]

CAMBRIDGE, Massachusetts, December 18, 2014 Claritas Genomics today announced the appointment of Patrick F. Terry to the role of Chief Commercial Officer. Mr. Terry, Chairman, Gray Group Ventures Ltd., and a founder of Genomic Health, Inc. [NASDAQ: GHDX], has been involved in shepherding multiple biotechnology products through commercial development to clinical delivery. Mr. Terry will […]

CAMBRIDGE, Mass., Dec. 11, 2014 To rapidly expand the use and power of genomic sequencing for diagnosing and treating rare diseases, Claritas Genomics and NextCODE Health today announced a strategic partnership bringing together global leadership in pediatric medicine and sequence analysis. Claritas Genomics, affiliated with Boston Children’s Hospital, is a CLIA-certified clinical laboratory serving the DNA-based […]

July 23, 2014: Dr. Yiping Shen, a Clinical Genetics Medical Director at Claritas Genomics presented a webinar sponsored by Agilent Technologies on Claritas’s ClariView Array, a microarray designed for patients with autism, developmental delay, or intellectual disability. More information about the webinar can be found by visiting Agilent’s website. Visit the ClariView Array webpage to […]

CAMBRIDGE, MA – July 31 Claritas Genomics, a clinical laboratory serving the DNA-based diagnostic testing needs of children’s hospitals, announced today that it is launching a novel series of clinical assays that combine the flexibility and comprehensiveness of whole exome sequencing with the rigor of deep and focused analysis of variants associated with specific clinical […]

Elizabeth Boudreau, Claritas’s Senior Manager of Information Technology, was invited by Amazon Web Services to speak at the June conference in Washington, DC. The conference, “AWS Government, Education, and Nonprofits Symposium,” invited leaders in public sectors to learn more about how the AWS cloud can support their work. Ms. Boudreau’s presentation, entitled “Enhancing Genetic Computation […]

At the 2014 Executive War College meeting in New Orleans, Patrice spoke with Adam Slone, CEO of Slone Partners about her path to becoming CEO of Claritas Genomics, how to foster a strong company culture, and what traits she looks for in a leadership team. Career Path – Company Culture – Leadership Traits

On May 1, 2014 at the Executive War College in New Orleans, Patrice spoke about Claritas Genomics’ evolution into a national genetic testing company. The title of her presentation was “Claritas Genomics: Transforming a Hospital-Based Molecular Lab into a Next-Generation Pediatric Diagnostic Company.”

FOR IMMEDIATE RELEASE Dec 5, 2013 KANSAS CITY, Mo. and CAMBRIDGE, Mass., Dec 05, 2013 (GLOBE NEWSWIRE via COMTEX) — Cerner Corp. CERN -0.14% and Claritas Genomics announce that the companies will work together to advance personalized medicine by building tools and connectivity that will better integrate next generation sequence (NGS)-based diagnostic testing into health […]